Break it Down: Recce partners with the US Army

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

Recce Pharmaceuticals (ASX:RCE) has partnered with the US Army Medical Research Institute of Infectious Diseases in an R&D deal focused on its anti-infective drug R327.

Watch the video to learn more.

While Recce Pharmaceuticals is a Stockhead advertiser, it did not sponsor this content.